| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/26/2026 | ±3.8% | +0.9% | over-priced |
| 08/03/2026 | ±3.7% | +3.1% | over-priced |
| 04/27/2026 | ±3.8% | -3.9% | under-priced |
| 01/26/2026 | ±2.6% | -4.2% | under-priced |
| 10/27/2025 | ±2.1% | +0.6% | over-priced |
| 07/21/2025 | ±2.5% | +0.1% | over-priced |
| 04/28/2025 | ±3.5% | +1.4% | over-priced |
| 01/27/2025 | ±2.1% | +0.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $-3.74 | $671M | $-638M |
| Q2 FY2026 | $-0.43 | $663M | $-73M |
| Q1 FY2026 | $2.10 | $671M | $362M |
| Q4 FY2025 | — | $754M | $-1.1B |
ARE (ARE) reports in 90 days, with the next report estimated for 01/25/2027. Across the last 8 reports, options priced an average ±3.0% earnings move while the stock actually moved 1.8% on average — the market has systematically over-priced ARE's earnings risk. Fundamentals into the print: EPS down 171.0% year-over-year, revenue down 10.7%. QuantLogix's live 5-factor engine currently reads ARE as a underweight at 46/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →